It is focused on developing Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation. Actinium Pharmaceuticals has been struggling lately, but the selling pressure may be coming to an end soon. If you share in this vision and are interested in joining the Actinium team please feel free to submit your resume by email to careers@actiniumpharma.com. The company was founded in 2002 and is headquartered in New York, NY. Find the latest Actinium Pharmaceuticals, Inc. (ATNM) stock quote, history, news and other vital information to help you with your stock trading and investing. Log in to see them here or sign up to get started.Create a list of the investments you want to track.Visit a quote page and your recently viewed tickers will be displayed here.Is (ATNM) Outperforming Other Medical Stocks This Year?Actinium Pharmaceuticals (ATNM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.United Therapeutics' (UTHR) INCREASE study evaluated Tyvaso in patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD).There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Actinium Pharmaceuticals (ATNM), Sanofi (SNYNF) ...[...]Is (ATNM) Outperforming Other Medical Stocks This Year?Actinium Pharmaceuticals announces reverse stock split 1-for-30Does Actinium Pharmaceuticals (ATNM) have what it takes to be a top stock pick for momentum investors? View highlights of Key Opinion Leaders discussing Iomab-B:Actinium Pharmaceuticals' drug development pipeline features Iomab-B, which is in a pivotal Phase 3 clinical trial, Actimab-A, which is in a Phase 2 clinical trial, and Actimab-M currently in a Phase 1 clinical trial.
Have Watchlists? Website www.actiniumpharma.com.
The firm provides its service through Iomab-B, which is studied in the ongoing pivotal Phase 3 Study of Iomab-B in Elderly Relapsed or Refractory Acute Myeloid Leukemia (SIERRA) trial for BMT conditioning. Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Actinium Provides Update on Iomab-B SIERRA Trial and Expected Topline Results from Ad Hoc Analysis in 2020 . 1-646-677-3875. Red Robin Gourmet Burgers shares rise after improved comp sales … Is (ATNM) Outperforming Other Medical Stocks This Year?The Zacks Analyst Blog Highlights: Alpine Immune Sciences, Actinium Pharmaceuticals, Pacira BioSciences and Translate BioHere we discuss four small stocks from the drug sector, which hold potential for a good run amid the coronavirus crisis.Actinium Pharmaceuticals, Inc. to Present at the 22nd Annual H.C. Wainwright Global Investor ConferenceGlobal Alpha Emitters Market 2020 Top countries data Analysis by Industry Trends, Size, Share, Company Overview, Growth, Development and Forecast by By 360 Market UpdatesGlobal Alpha Emitters Market 2020 Top countries data Industry Trends, Share, Size, Demand, Growth Opportunities, Industry Revenue, Future and Business Analysis by Forecast By 360 Market UpdatesImpact Of Covid-19 On Radiopharmaceutical Market To Witness Significant Growth By 2020-2029 With Key Player- Cardinal Health, Mallinckrodt., General Electric Company, Lantheus Medical ImagingNuclear Medicine-Radiopharmaceuticals Market Share 2020: Global Key Findings, Industry Demand, Regional Analysis,Impact of Covid-19 on Industry, Key Players Profiles, Future Prospects and Forecasts to 2025Global Myelodysplastic Syndrome Market 2020 Industry Size and Share Evolution to 2026 by Growth Insight, Key Development, Trends and Forecast by Market Reports WorldAlpha Emitters Market Global Insights and Growing Trend Analysis 2020-2026Changes in Institutional Ownership Signals Bullish Stocks: $TRCH $ATNM $WISAActinium Pharmaceuticals, Inc. ATNM 7.39 0.13 (1.79%). Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Phone. Announces Pricing of $27.5 Million Public Offering . Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing ARC’s or Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation. Announces Proposed Public Offering . Actinium Pharmaceuticals. Announces Reverse Stock SplitAlpha Emitters Market Share, Size Global Historical Analysis,Industry Key Strategies, Segmentation, Application, Technology, Trends and Opportunities Forecasts to 2024Global Alpha Emitters Market Top Countries Data 2020 Industry Overview, Key Players Analysis, Emerging Opportunities, Comprehensive Research Study, Competitive Landscape and Potential of Industry from 2020-2024 By 360 Market UpdatesThinking about buying stock in Carnival Corp, Actinium Pharmaceuticals, United Airlines Holdings, Uber Technologies, or Fastly Inc?Global Alpha Emitters Market Top Countries Data 2020 Industry Overview, Key Players Analysis, Emerging Opportunities, Comprehensive Research Study, Competitive Landscape and Potential of Industry from By 360 Market UpdatesAlpha Emitters Market Share, Size Global Leading Players, Industry Updates, Future Growth, Business Prospects, Forthcoming Developments and Future Investments by Forecast to 2024Global Alpha Emitters Market Top Countries Data 2020: Industry Size, Share, Future Challenges, Revenue, Demand, Industry Growth and Top Players Analysis By 360 Market UpdatesThinking about buying stock in Vivint Solar, Actinium Pharmaceuticals, Delta Air Lines, Sunesis Pharmaceuticals, or Novan Inc?Global Alpha Emitters Market 2020 analysis with Key Players, Applications, Trends and Forecasts by 2025Thinking about buying stock in BioNano Genomics, Actinium Pharmaceuticals, General Electric, Delta Air Lines, or TOP Ships?Relapsed Acute Myeloid Leukemia Drug Market 2020 Research Report With COVID-19 Update, Growth Strategy and Industry Development to 2026COVID-19 UPDATE: Radiopharmaceuticals Market Astonishing Growth | Top Competitors like Cardinal Health, Mallinckrodt., General Electric Company, Lantheus Medical Imaging, Inc., Bayer AG Apr 21, 2020. Address. Actinium Pharmaceuticals, Inc. is focused on developing therapies for the treatment of cancer patients with unmet needs with the goal of improving patients’ outcomes. It is focused on developing Antibody Radiation-Conjugates, which combine the … Actinium Pharmaceuticals serves patients in the State of New York. Actinium is focused on continuing to expand its drug development pipeline by leveraging its alpha-particle technology platform and domain expertise.